Dr. Reddy's inks deal with Merck

Dr. Reddy's Laboratories has entered into an agreement with Merck to distribute and sell generic versions of Proscar and Zocor upon the expiry of Merck's patents on the products.

This was announced in a release issued by Dr. Reddy's to the BSE today.

"The company will distribute the products provided there is a 180-day exclusivity after patent expiration," the release added.